Methyl 4-((6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)benzoate, 97.0%, 100mg

1,1,1-Tris(2-cyanoethyl)nitromethane, 96%, 5g

L(-)-malic acid, min. 99%, for biochemistry, 10 g, plastic packaging.

2-Bromo-4,5-difluorobenzenesulfonyl chloride, 95.0%, 5g

2-Bromo-4-(3,3-difluoroazetidin-1-yl)pyridine, 250mg

Tert-butyl 2-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-1-carboxylate, 95%, 100mg

1-(4-Nitrophenyl)pyrrolidine, 98%, 10g

4-Butoxyaniline, 97.0%, 5g

(2R,6R)-2,6-Dimethylmorpholine, 95.0%, 250mg

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide, 98%, 1g

Ethyl 2-amino-4-cyclopropylthiophene-3-carboxylate, 95.0%, 2.5g

4-(aminomethyl)-N,N-dimethylbenzamide hydrochloride, 95.0%, 10g

7-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one, 95.0%, 2.5g